What makes Genmab extra[not]ordinary

7 February 2024 - Online

During the presentation Azra will highlight Genmab’s mission and ambition, what type of activities we do in Utrecht and how that fits into the therapeutic antibody development process. She will also discuss her own career path, how she got there and her activities at Genmab. During the presentation you will understand why Genmab is extra[not] ordinary and why it is a great place to work for any career level!

Azra Mujić-Delić | Principal Scientist, Functional Characterization & Bioassays | Genmab

Azra has obtained her Masters degree in Drug Discovery & Safety at VU University in Amsterdam, followed by a PhD in Receptor Biochemistry & signaling at the same university. She joined Janssen Vaccines as analytical development scientist in 2013, with main focus on molecular and bioassay development for release, stability and characterization of clinical vaccine candidates. In 2019 Azra joined Genmab as Senior Scientist bioassay development and functional characterization of antibody-based cancer therapeutics in late stage clinical development. Azra is now Principal Scientist within the same focus area in the CMC Science and Technologies department at Genmab.

FULL PROGRAMME HERE